Journal article · 2015

Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance

Lindsey E. Minion, Robert Louis Coleman, Ronald David Alvarez, Thomas J. Herzog

Gynecologic Oncology, 140(2), 193–198 · Published 27 November 2015 · DOI 10.1016/j.ygyno.2015.11.030

View at the publisherCite this paper

In brief

“Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance” is a 2015 journal article by Lindsey E. Minion and 3 co-authors, published in Gynecologic Oncology. OpenAlex counts 46 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
46
Most cited in
2020 (9)
Field-weighted impact
2.23
References
18
Authors
4

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Minion, L. E., Coleman, R. L., Alvarez, R. D., & Herzog, T. J. (2015). Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance. Gynecologic Oncology, 140(2), 193–198. https://doi.org/10.1016/j.ygyno.2015.11.030

MLA 9

Minion, Lindsey E., et al. “Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance.” Gynecologic Oncology, vol. 140, no. 2, 2015, pp. 193–198. https://doi.org/10.1016/j.ygyno.2015.11.030.

Chicago

Minion, Lindsey E., Robert Louis Coleman, Ronald David Alvarez, and Thomas J. Herzog. 2015. “Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance.” Gynecologic Oncology 140 (2): 193–198. https://doi.org/10.1016/j.ygyno.2015.11.030.

Harvard

Minion, L. E. et al. (2015) ‘Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance’, Gynecologic Oncology, 140(2), pp. 193–198. doi:10.1016/j.ygyno.2015.11.030.

IEEE

L. E. Minion, R. L. Coleman, R. D. Alvarez, and T. J. Herzog, “Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance,” Gynecologic Oncology, vol. 140, no. 2, pp. 193–198, 2015, doi: 10.1016/j.ygyno.2015.11.030.

BibTeX

@article{minion2015endpoints,
  title     = {{Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance}},
  author    = {Minion, Lindsey E. and Coleman, Robert Louis and Alvarez, Ronald David and Herzog, Thomas J.},
  journal   = {Gynecologic Oncology},
  year      = {2015},
  volume    = {140},
  number    = {2},
  pages     = {193--198},
  doi       = {10.1016/j.ygyno.2015.11.030},
  url       = {https://doi.org/10.1016/j.ygyno.2015.11.030}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201411
201644
201777
201866
201977
202099
202233
202333
202433
202533

Its field-weighted citation impact is 2.23: it has been cited 2.23 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment

  • patient preferences
  • clinical trial endpoints
  • ovarian cancer
  • surrogate endpoints
  • progression-free survival
  • overall survival
  • treatment toxicity
  • quality of life

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Minion, L. E., Coleman, R. L., Alvarez, R. D., & Herzog, T. J. (2015). Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance. Gynecologic Oncology, 140(2), 193–198. https://doi.org/10.1016/j.ygyno.2015.11.030

How many times has this paper been cited?

46 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Lindsey E. Minion, Robert Louis Coleman, Ronald David Alvarez, Thomas J. Herzog.

What is the DOI of this paper?

10.1016/j.ygyno.2015.11.030, permanently at https://doi.org/10.1016/j.ygyno.2015.11.030. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.